Rezatomidine

CAS No. 847829-38-3

Rezatomidine ( AGN-203818; AGN203818; AGN 203818 )

Catalog No. M28010 CAS No. 847829-38-3

Rezatomidine (AGN-203818) is an effective and selective alpha2-adrenergic receptor antagonist for the treatment of chronic pain, including neuropathic pain.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 264 Get Quote
5MG 403 Get Quote
10MG 592 Get Quote
25MG 888 Get Quote
50MG 1242 Get Quote
100MG 1701 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Rezatomidine
  • Note
    Research use only, not for human use.
  • Brief Description
    Rezatomidine (AGN-203818) is an effective and selective alpha2-adrenergic receptor antagonist for the treatment of chronic pain, including neuropathic pain.
  • Description
    Rezatomidine (AGN-203818) is an effective and selective alpha2-adrenergic receptor antagonist for the treatment of chronic pain, including neuropathic pain.
  • Synonyms
    AGN-203818; AGN203818; AGN 203818
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    BRM/BRG1
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    847829-38-3
  • Formula Weight
    232.4
  • Molecular Formula
    C13H16N2S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C[C@H](c1c[nH]c(=S)[nH]1)c1cccc(C)c1C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Neville John ANTHONY, et al. Compounds and uses thereof. WO2019152437A1.
molnova catalog
related products
  • MKC3946

    MKC3946 is an effective and soluble IRE1α inhibitor which triggered modest growth inhibition in multiple myeloma cell lines.

  • Triglochinic acid

    Triglochinic acid is a monomeric compound isolated from tubers of Pinellia pedatisecta Schott.

  • LtaS-IN-1

    LtaS-IN-1 is an effective inhibitor of Lipoteichoic acid synthesis in multidrug-resistant (MDR) E. faecium and by altering the cell wall morphology.